JP2014515372A5 - - Google Patents

Download PDF

Info

Publication number
JP2014515372A5
JP2014515372A5 JP2014512145A JP2014512145A JP2014515372A5 JP 2014515372 A5 JP2014515372 A5 JP 2014515372A5 JP 2014512145 A JP2014512145 A JP 2014512145A JP 2014512145 A JP2014512145 A JP 2014512145A JP 2014515372 A5 JP2014515372 A5 JP 2014515372A5
Authority
JP
Japan
Prior art keywords
crystalline form
cyclosporin
ophthalmically acceptable
crystalline
diffraction pattern
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014512145A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014515372A (ja
JP6163482B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/039611 external-priority patent/WO2012166610A1/en
Publication of JP2014515372A publication Critical patent/JP2014515372A/ja
Publication of JP2014515372A5 publication Critical patent/JP2014515372A5/ja
Application granted granted Critical
Publication of JP6163482B2 publication Critical patent/JP6163482B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014512145A 2011-05-27 2012-05-25 シクロスポリンaの結晶形態、その調製方法、およびその使用のための方法 Expired - Fee Related JP6163482B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161490887P 2011-05-27 2011-05-27
US61/490,887 2011-05-27
PCT/US2012/039611 WO2012166610A1 (en) 2011-05-27 2012-05-25 A crystalline form of cyclosporine a, methods of preparation, and methods for use thereof

Publications (3)

Publication Number Publication Date
JP2014515372A JP2014515372A (ja) 2014-06-30
JP2014515372A5 true JP2014515372A5 (cg-RX-API-DMAC7.html) 2015-04-30
JP6163482B2 JP6163482B2 (ja) 2017-07-12

Family

ID=46178866

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014512145A Expired - Fee Related JP6163482B2 (ja) 2011-05-27 2012-05-25 シクロスポリンaの結晶形態、その調製方法、およびその使用のための方法

Country Status (19)

Country Link
US (4) US8772245B2 (cg-RX-API-DMAC7.html)
EP (2) EP2714720B1 (cg-RX-API-DMAC7.html)
JP (1) JP6163482B2 (cg-RX-API-DMAC7.html)
KR (1) KR102079402B1 (cg-RX-API-DMAC7.html)
CN (1) CN103649108B (cg-RX-API-DMAC7.html)
AR (1) AR086586A1 (cg-RX-API-DMAC7.html)
AU (4) AU2012262513B2 (cg-RX-API-DMAC7.html)
BR (1) BR112013030554B1 (cg-RX-API-DMAC7.html)
CA (1) CA2836946C (cg-RX-API-DMAC7.html)
CL (1) CL2013003400A1 (cg-RX-API-DMAC7.html)
IL (2) IL229475A0 (cg-RX-API-DMAC7.html)
MX (1) MX362271B (cg-RX-API-DMAC7.html)
MY (1) MY180581A (cg-RX-API-DMAC7.html)
RU (1) RU2602062C2 (cg-RX-API-DMAC7.html)
SG (1) SG10201607344UA (cg-RX-API-DMAC7.html)
TW (1) TWI554522B (cg-RX-API-DMAC7.html)
UA (1) UA113627C2 (cg-RX-API-DMAC7.html)
WO (1) WO2012166610A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201308665B (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102029513B1 (ko) * 2011-11-15 2019-10-07 알러간, 인코포레이티드 사이클로스포린 제2형의 지속 작용 제형
JP6363506B2 (ja) 2011-11-15 2018-07-25 アラーガン、インコーポレイテッドAllergan,Incorporated シクロスポリンa2型の懸濁剤
CN108714137B (zh) * 2011-11-15 2022-02-01 阿勒根公司 环孢菌素a形式2的可热压性悬浮液
CN104039813B (zh) 2011-11-15 2017-08-29 阿勒根公司 环孢菌素a形式2及其制备方法
WO2013181339A2 (en) 2012-06-01 2013-12-05 Allergan, Inc. Cyclosporin a analogs
GB201222455D0 (en) * 2012-12-13 2013-01-30 Perioc Ltd Novel pharmaceutical formulations and their use in the treatment of periodontaldisease
US10524661B2 (en) * 2013-06-12 2020-01-07 Proactive Live, Inc. Sleep monitoring and stimulation
RU2713953C2 (ru) * 2014-07-18 2020-02-11 Аллерган, Инк. Суспензионные составы циклоспорина а для субконъюнктивального и периокулярного введения
TW201639873A (zh) 2015-01-08 2016-11-16 歐樂根公司 Mebmt側鏈已環化之環孢菌素衍生物
US10443292B2 (en) * 2016-04-25 2019-10-15 Magna Closures, Inc. Non-contact obstacle detection system for motor vehicles
US12037415B2 (en) * 2017-05-17 2024-07-16 Yuyu Pharma, Inc. Peptide and pharmaceutical composition for treating an eye disease comprising the same as an active pharmaceutical ingredient
US11613558B2 (en) 2018-11-14 2023-03-28 Yuyu Pharma, Inc. Peptides and pharmaceutical compositions for treating eye diseases
US20240342086A1 (en) * 2021-08-20 2024-10-17 Sun Pharmaceutical Industries Limited Stable cyclosporine ophthalmic formulation and manufacturing process thereof
US20260132169A1 (en) 2022-10-20 2026-05-14 Chugai Seiyaku Kabushiki Kaisha Method for producing cyclic peptide crystals
CN120731215A (zh) 2023-03-20 2025-09-30 中外制药株式会社 用于产生环肽的共晶的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU203564B (en) * 1987-12-21 1991-08-28 Sandoz Ag Process for producing new orthorombos cyclosporin without solvatation
GB9105705D0 (en) * 1991-03-18 1991-05-01 Sandoz Ltd Improvements in or relating to organic compounds
US5474979A (en) * 1994-05-17 1995-12-12 Allergan, Inc. Nonirritating emulsions for sensitive tissue
US6254860B1 (en) 1999-04-13 2001-07-03 Allergan Sales, Inc. Ocular treatment using cyclosporin-A derivatives
US6656504B1 (en) * 1999-09-09 2003-12-02 Elan Pharma International Ltd. Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions
CN101687013A (zh) * 2007-05-04 2010-03-31 阿勒根公司 环孢菌素在治疗具有人工晶状体的患者中的用途
CN101990437A (zh) * 2008-01-04 2011-03-23 阿尔康药品有限公司 稳定的环孢菌素水性组合物

Similar Documents

Publication Publication Date Title
RU2013155033A (ru) Кристаллическая форма циклоспорина а, способы ее получения и способы применения
JP2024516371A5 (cg-RX-API-DMAC7.html)
JP2013032389A5 (cg-RX-API-DMAC7.html)
EA201391158A1 (ru) Диаминиевые соли фенотиазина и их применение
JP2013516473A5 (cg-RX-API-DMAC7.html)
ES2782509T3 (es) Procedimiento para la preparación de 1,2,4-oxadiazoles 3,5-disustituidos
JP2015537020A5 (cg-RX-API-DMAC7.html)
CO6561780A2 (es) Fromas polomorficas , cristalinas y de mesofase de 2-(5- bromo-4(4-ciclopropilnaftalen -1-il) -ah-1,2,4- triazol-3-iltio)acetato de sodio, y usos de las mismas
JP2019504103A5 (cg-RX-API-DMAC7.html)
RU2017102513A (ru) Соль гетероциклического соединения, замещенного галогеном
JP2015526453A5 (cg-RX-API-DMAC7.html)
JP2007532560A5 (cg-RX-API-DMAC7.html)
US20170015696A1 (en) Solid state forms of sofosbuvir
JP2016521695A5 (cg-RX-API-DMAC7.html)
CN103709120B (zh) 一种盐酸阿考替胺三水合物的制备方法
CN103910663B (zh) 一种具有抗菌活性的截短侧耳素衍生物及其制备和应用
JP2016510767A5 (cg-RX-API-DMAC7.html)
JP2012511558A5 (cg-RX-API-DMAC7.html)
CN103709191A (zh) 一种盐酸阿考替胺的合成方法
JP2013541589A5 (cg-RX-API-DMAC7.html)
JP2011529942A5 (cg-RX-API-DMAC7.html)
US20180215715A1 (en) Solid state forms of netarsudil mesylate
JP2021091670A5 (cg-RX-API-DMAC7.html)
JP2015531354A5 (cg-RX-API-DMAC7.html)
CN103288804A (zh) 一种尼洛替尼的制备方法